Lv4
610 积分 2025-10-29 加入
Comprehensive management of MET tyrosine kinase inhibitor-induced peripheral edema in patients with MET-altered non-small-cell lung cancer: a narrative review
17天前
已完结
Impact of previous corticosteroid exposure on outcomes of patients receiving immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective observational study
1个月前
已完结
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials
1个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
2个月前
已完结
Chemotherapy Primary Dose Reduction in Older Cancer Patients: A Retrospective Cohort
3个月前
已关闭
Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration
3个月前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
3个月前
已完结
Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer
3个月前
已完结
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial
3个月前
已完结
皖公网安备34019202002308
